Why language is important in prostate cancer management

We have emphasized this before, but we want to talk about it again because it recently came up in a general primary care journal: “active surveillance” and “watchful waiting” are often used interchangeably — by patients and their partners and by some doctors too … but they aren’t the same thing at all. … READ MORE …

Impact of OSGs on patient decision-making and treatment for localized prostate cancer

Since Prostate Cancer International runs an online support group (OSG) for patients, we were obviously very interested to see a newly published article by a German research group on the effects of OSGs on patients’ decision-making processes. … READ MORE …

Refining the criteria for selection of patients suitable for active surveillance

The question of how best to set the spectrum of criteria that indicate the suitability of an individual patient as a good candidate for active surveillance as opposed to early treatment is (as yet) not well answered. … READ MORE …

Of liquid biopsies, CTCs, and first-line treatment for mCRPC

A paper to be presented at the Genitourinary Cancers Synposium today, suggests that use of a liquid biopsy and analysis of single circulating tumor cells (CTCs) may be helpful in determining therapy for men with metastatic, castration-resistant prostate cancer (mCRPC). … READ MORE …

Selection of appropriate candidates for management with active surveillance

In this month’s issue of the Journal of Urology, Dr. Peter Carroll (of UCSF) and Dr. Mark Dall’Era (formerly of UCSF and now at UCDavis) have contributed an editorial entitled “What is the optimal way to select candidates for active surveillance of prostate cancer?” … READ MORE …

More reports from the annual meeting of the Society for Urologic Oncology

This morning we have a series of four more prostate cancer-related summary reports from the 14th annual meeting of the Society for Urologic Oncology (SUO) available on the UroToday web site (which is freely accessible to patients, but you do have to register to access it). … READ MORE …

How many current, PSA-detected, localized prostate cancers are really appropriate for focal therapy?

It is well understood that current Western screening and diagnostic processes commonly identify patients with low volume, low Gleason grade prostate cancer tumors (e.g., a single biopsy core with < 10 percent of the core  positive for cancer of Gleason score 3 + 3 = 6). … READ MORE …